Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
PLoS One. 2013 Aug 7;8(8):e69404. doi: 10.1371/journal.pone.0069404. eCollection 2013.
Protein tyrosine phosphatase non-receptor type 22 (PTPN22) is a negative regulator of T-cell activation associated with several autoimmune diseases, including systemic lupus erythematosus (SLE). Missense rs2476601 is associated with SLE in individuals with European ancestry. Since the rs2476601 risk allele frequency differs dramatically across ethnicities, we assessed robustness of PTPN22 association with SLE and its clinical sub-phenotypes across four ethnically diverse populations. Ten SNPs were genotyped in 8220 SLE cases and 7369 controls from in European-Americans (EA), African-Americans (AA), Asians (AS), and Hispanics (HS). We performed imputation-based association followed by conditional analysis to identify independent associations. Significantly associated SNPs were tested for association with SLE clinical sub-phenotypes, including autoantibody profiles. Multiple testing was accounted for by using false discovery rate. We successfully imputed and tested allelic association for 107 SNPs within the PTPN22 region and detected evidence of ethnic-specific associations from EA and HS. In EA, the strongest association was at rs2476601 (P = 4.7 × 10(-9), OR = 1.40 (95% CI = 1.25-1.56)). Independent association with rs1217414 was also observed in EA, and both SNPs are correlated with increased European ancestry. For HS imputed intronic SNP, rs3765598, predicted to be a cis-eQTL, was associated (P = 0.007, OR = 0.79 and 95% CI = 0.67-0.94). No significant associations were observed in AA or AS. Case-only analysis using lupus-related clinical criteria revealed differences between EA SLE patients positive for moderate to high titers of IgG anti-cardiolipin (aCL IgG >20) versus negative aCL IgG at rs2476601 (P = 0.012, OR = 1.65). Association was reinforced when these cases were compared to controls (P = 2.7 × 10(-5), OR = 2.11). Our results validate that rs2476601 is the most significantly associated SNP in individuals with European ancestry. Additionally, rs1217414 and rs3765598 may be associated with SLE. Further studies are required to confirm the involvement of rs2476601 with aCL IgG.
蛋白酪氨酸磷酸酶非受体型 22(PTPN22)是一种与多种自身免疫性疾病相关的 T 细胞激活的负调节剂,包括系统性红斑狼疮(SLE)。错义 rs2476601 与欧洲血统的个体中的 SLE 相关。由于 rs2476601 风险等位基因频率在不同种族之间差异巨大,因此我们评估了 PTPN22 与 SLE 及其临床亚表型在四个不同种族人群中的关联的稳健性。在欧洲裔美国人(EA)、非裔美国人(AA)、亚洲人(AS)和西班牙裔(HS)中,对 8220 例 SLE 病例和 7369 例对照中的 10 个 SNP 进行了基因分型。我们进行了基于 imputation 的关联分析,然后进行了条件分析以确定独立关联。对与 SLE 临床亚表型相关的显着相关 SNP 进行了检测,包括自身抗体谱。通过使用错误发现率来考虑多重检测。我们成功地对 PTPN22 区域内的 107 个 SNP 进行了 imputation 和等位基因关联测试,并从 EA 和 HS 中检测到了种族特异性关联的证据。在 EA 中,最强的关联位于 rs2476601(P = 4.7×10(-9),OR = 1.40(95%CI = 1.25-1.56))。在 EA 中还观察到与 rs1217414 的独立关联,并且这两个 SNP 均与增加的欧洲血统相关。对于 HS imputed 内含子 SNP rs3765598,预测为 cis-eQTL,与 rs3765598 相关(P = 0.007,OR = 0.79 和 95%CI = 0.67-0.94)。在 AA 或 AS 中未观察到显着关联。使用狼疮相关临床标准进行的病例仅分析显示,在 rs2476601 处 IgG 抗心磷脂抗体(aCL IgG >20)中滴度中等至高的 EA SLE 患者与 aCL IgG 阴性的患者之间存在差异(P = 0.012,OR = 1.65)。当将这些病例与对照组进行比较时,关联得到了加强(P = 2.7×10(-5),OR = 2.11)。我们的结果验证了 rs2476601 是欧洲血统个体中最显着相关的 SNP。此外,rs1217414 和 rs3765598 可能与 SLE 相关。需要进一步的研究来确认 rs2476601 与 aCL IgG 的关系。